Alterations in Neuromodulatory Proteins in Single APP Knock-in Mice Assessed Following Ketamine Therapy
ISEF · 2024 Biochemistry
Overview
Alzheimer's disease (AD) poses a global health challenge, necessitating a deeper exploration of its etiology for effective interventions. This study investigates the impact of ketamine, an NMDA receptor antagonist, on neuromodulatory proteins in the context of AD using App knock-in mice, enhancing translational relevance. Neuromodulatory pathways, including glutamate, GABA, BDNF, and the mTOR signaling pathway, are central to cognitive processes and often dysregulated in AD. Ketamine's potential therapeutic effects are explored through behavioral tests assessing recognition memory (novel object recognition), depressive behavior (forced swim test), and spatial memory (Y-maze). Ketamine treatment in the App Ketamine group led to significant alterations in neuromodulatory complexes in the prefrontal cortex (PFC), hippocampus (HPC), and amygdala (AMY). IHC quantification and Western Blot assays were performed using primary antibody solutions and after fractioning isolated MF hippocampal proteins by SDS-polyacrylamide gel electrophoresis. In the PFC, ketamine induced an increase in glutamate, a decrease in glutamine, and a reduction in GABA levels, showcasing its impact on neurotransmitter systems. The hippocampus exhibited elevated BDNF levels, reduced GSK-3, and increased PSD-95, suggesting ketamine's potential to enhance synaptic plasticity. The amygdala, linked to emotional processing, displayed decreased BDNF and AMPA GluA1 levels. Behavioral assessments revealed ketamine and genotype-induced improvements in recognition memory, cognitive flexibility, and depressive-like behavior. The study emphasizes the need for personalized therapeutic strategies, due to the interplay between ketamine, genetics, and neuromodulatory pathways in the pursuit of effective AD treatments.
Competition history
- ISEF 2024
Resources
Related projects
ISEF · 2019
Arc, GAD67, and the Orbitofrontal Cortex: Reconsidering the Molecular and Systemic Basis of Major Depressive Disorder
ISEF · 2018
The Effects of Beta-Hydroxybutyrate on the Effects of Beta-Amyloid in Caenorhabditis elegans
ISEF · 2024
The Effect of a-ketoglutarate on a Tau-Based Model of Neurodegeneration in Drosophila melanogaster
ISEF · 2019
Effects of Insulin-Like Growth Factor-1 on Neurotransmitters of Memory
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair